Lilly’s Application For Once-Monthly Zyprexa Is Pending At FDA

Olanzapine depot is expected to get a standard 10-month review following submission of an NDA in the second quarter, Lilly says.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet